Moderna beats on revenue but loses more than expected as it scales down manufacturing
Pending US vaccine decisions as Kennedy takes top health job
Bristol Myers Squibb comes up short in bid to expand Opdualag in melanoma
Corbus posts first US data on challenger to Pfizer’s ADC Padcev
*please scroll down for all the latest news*
